Essity reports third-quarter results as Essity B stock costs EUR 24.37

Published on 10/22/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales rose 4.10 percent to SEK 36.06 billion. Essity B stock costs EUR 24.37 on October 22, 2026 at SEK 182.6 billion market value.

Quarterly figures and acquisition

Essity reported SEK 36,060 million in sales for the third quarter of 2026.
Adjusted EBITA reached SEK 4,725 million versus consensus of SEK 4,414 million on October 22, 2026.
Essity B stock traded at EUR 24.37 at 12:00 p.m. CEST on October 22, 2026.

Essity AB SE0009922164: Isometrisches 3D-Diagramm der Wertschöpfungskette — Essity AB (ISIN SE0009922164) visualisiert die Wertschöpfungskette der Hygienepapierherstellung als isometrisches 3D-Prozessdiagramm, Illustration mit AI erstellt.

Essity B (ISIN SE0009922164) was trading at EUR 24.37 at Lang & Schwarz on October 22, 2026 at 12:00 p.m. CEST. The company reported third-quarter results that combined higher sales with weaker organic growth, according to Cision on October 22, 2026.

Sales rise while volumes soften

Essity generated SEK 36,060 million in sales in the third quarter of 2026, up 4.10 percent from SEK 34,638 million in the year-earlier quarter. Organic sales growth was minus 0.30 percent, with volume down 0.10 percent and price and mix down 0.20 percent, the company said in the report.

The result was mixed across divisions. Personal Care delivered 3.20 percent organic growth, while Consumer Tissue declined 3.00 percent and Professional Hygiene fell 1.10 percent. Health and Medical grew 1.20 percent, giving investors a clear split between the faster-growing care businesses and weaker tissue demand.

What does the margin mean?

Adjusted EBITA excluding items affecting comparability reached SEK 4,725 million in the third quarter, 7.04 percent above the consensus estimate of SEK 4,414 million, according to Investing.com on October 22, 2026. The adjusted EBITA margin excluding items affecting comparability was 13.10 percent, below 14.60 percent in the year-earlier quarter, as cost pressure continued.

Cash generation provided a counterweight. Operating cash flow was SEK 5,783 million in the third quarter of 2026, above SEK 5,324 million a year earlier. The report also said Essity had agreed to acquire Kenvue's feminine care business in Brazil, with completion expected in the second quarter of 2027.

Acquisition adds a growth date

The Brazilian transaction includes the Carefree, Sempre Livre and o.b. brands and expands Essity's feminine care position in Latin America. According to Cision, regulatory approval is required and the deal is expected to close in the second quarter of 2027.

Essity also said its strategic review of Consumer Tissue was proceeding according to plan on October 22, 2026. Management is evaluating either a separation or continued ownership, with the stated aim of improving long-term value creation.

Stock value after the report

Essity B has a market capitalization of SEK 182.6 billion as of October 22, 2026. The combination of a 4.10 percent sales increase, a 13.10 percent adjusted margin and SEK 5,783 million in operating cash flow gives the report a stronger cash profile than its organic growth figure suggests.

Essity B stock was trading at EUR 24.37 at Lang & Schwarz on October 22, 2026 at 12:00 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Essity B stock.